Phibro Animal Health Corporation

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It partners with livestock producers, farmers, veterinarians, and consumers to provide solutions for maintaining and enhancing animal health. The company markets approximately 790 product lines in approximately 90 countries to approximately 4,800 customers. Phibro develops, manufactures, and markets a broad range of products for food animals, including poultry, beef and dairy cattle, swine, aquaculture, and dogs, which help prevent, control, and treat diseases and support nutrition. Products are sold directly to integrated poultry, cattle, and swine producers, or through animal feed manufacturers, wholesalers, distributors, and veterinarians. Key offerings include Animal Health products such as antibacterials, anticoccidials, nutritional specialty products, and vaccines and vaccine adjuvants, which improve animal health, performance, food safety, and welfare. The Animal Health segment also includes antibacterials and other processing aids for the ethanol fermentation industry. Mineral nutrition products fortify animal diets and help maintain optimal health. Phibro focuses on regions with consolidated livestock production in large commercial farms, with established sales, marketing, and distribution networks in North America, Latin America, Asia Pacific, Europe, Africa, and the Middle East. While currently concentrated in the livestock sector, the company is investing in companion animal products. Additionally, Phibro manufactures and markets specific ingredients for the personal care, industrial chemical, and chemical catalyst industries, selling these performance products directly to customers. The company's Class A common stock trades on Nasdaq under the symbol "PAHC."